What does a high Free Androgen Index mean?

A high Free Androgen Index (FAI) indicates elevated levels of active testosterone in your body, which can cause symptoms like acne, hair loss, and irregular periods in women or mood changes in men. The condition often stems from hormonal imbalances, PCOS, or metabolic issues and requires proper testing and management.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Free Androgen Index

The Free Androgen Index (FAI) is a calculated value that estimates the amount of biologically active testosterone circulating in your bloodstream. Unlike total testosterone measurements, which include both bound and unbound hormones, FAI provides insight into the testosterone that's actually available for your body to use. This distinction is crucial because only free testosterone can enter cells and trigger biological responses.

FAI is calculated using a simple formula: (Total Testosterone / Sex Hormone Binding Globulin) × 100. Sex Hormone Binding Globulin (SHBG) is a protein that binds to sex hormones, including testosterone, making them inactive. When SHBG levels are low or testosterone levels are high, more free testosterone becomes available, resulting in a higher FAI.

Understanding your FAI levels can provide valuable insights into various health conditions, from polycystic ovary syndrome (PCOS) in women to metabolic syndrome in both sexes. Regular monitoring through comprehensive hormone testing can help identify imbalances early and guide appropriate interventions.

Free Androgen Index Reference Ranges

Reference ranges may vary slightly between laboratories. Results should be interpreted in conjunction with symptoms and other clinical findings.
PopulationNormal RangeElevated RangeClinical Significance
Women (Reproductive Age)Women (Reproductive Age)0.5-6.0>6.0May indicate PCOS, metabolic syndrome, or other hyperandrogenic conditions
Women (Postmenopausal)Women (Postmenopausal)0.3-4.0>4.0Could suggest adrenal disorders or hormone-producing tumors
MenMen15-95>95May indicate exogenous testosterone use, tumors, or metabolic dysfunction

Reference ranges may vary slightly between laboratories. Results should be interpreted in conjunction with symptoms and other clinical findings.

Normal FAI Ranges and What High Levels Mean

Normal FAI ranges vary significantly between men and women due to natural differences in testosterone production. Understanding these reference ranges helps contextualize your results and determine whether intervention is necessary.

For women, a normal FAI typically ranges from 0.5 to 6.0, though some laboratories use slightly different reference ranges. An FAI above 6.0 in women is generally considered elevated and may indicate hyperandrogenism, a condition characterized by excess male hormones. In men, normal FAI ranges are considerably higher, typically between 15 to 95, with values above this range suggesting elevated free testosterone activity.

A high FAI means that a greater proportion of your testosterone is unbound and biologically active. This can occur either because your total testosterone is elevated, your SHBG is low, or both. The clinical significance of a high FAI depends on your sex, symptoms, and other health factors.

Symptoms of High Free Androgen Index

Symptoms in Women

Women with elevated FAI often experience a constellation of symptoms related to excess androgen activity. These manifestations can significantly impact quality of life and may develop gradually over months or years.

  • Hirsutism (excessive hair growth on face, chest, back, or abdomen)
  • Acne, particularly along the jawline and chin
  • Male-pattern baldness or thinning hair on the scalp
  • Irregular menstrual periods or absence of periods
  • Difficulty getting pregnant
  • Weight gain, especially around the midsection
  • Darkening of skin in body creases (acanthosis nigricans)
  • Mood changes, including increased irritability or aggression

Symptoms in Men

While men naturally have higher testosterone levels, excessively high FAI can still cause problematic symptoms:

  • Aggressive behavior or mood swings
  • Acne, particularly on the back and shoulders
  • Premature balding
  • Increased muscle mass (though this may be desired in some cases)
  • High blood pressure
  • Elevated red blood cell count
  • Sleep apnea
  • Reduced sperm count (paradoxically)

Common Causes of Elevated FAI

Polycystic Ovary Syndrome (PCOS)

PCOS is the most common cause of elevated FAI in women of reproductive age, affecting up to 10% of women worldwide. This complex endocrine disorder involves multiple hormonal imbalances, including elevated androgens, insulin resistance, and often low SHBG levels. Women with PCOS typically have FAI values 2-3 times higher than normal, contributing to many of the syndrome's characteristic symptoms.

Metabolic and Lifestyle Factors

Several metabolic and lifestyle factors can contribute to high FAI by either increasing testosterone production or decreasing SHBG levels:

  • Insulin resistance and Type 2 diabetes (insulin suppresses SHBG production)
  • Obesity (fat tissue can convert other hormones to testosterone)
  • High-sugar and high-processed food diets
  • Chronic stress (elevates cortisol, which can affect sex hormone balance)
  • Certain medications (anabolic steroids, some birth control pills)
  • Thyroid disorders (both hyper- and hypothyroidism can affect SHBG)

Other Medical Conditions

Less common causes of elevated FAI include congenital adrenal hyperplasia, androgen-secreting tumors of the ovaries or adrenal glands, and Cushing's syndrome. These conditions typically present with more severe symptoms and require specialized medical evaluation and treatment.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Health Implications of High FAI

Chronically elevated FAI can have significant long-term health consequences beyond the immediate symptoms. Understanding these risks emphasizes the importance of proper diagnosis and management.

In women, persistently high FAI is associated with an increased risk of metabolic syndrome, characterized by insulin resistance, abdominal obesity, high blood pressure, and abnormal cholesterol levels. This metabolic dysfunction significantly elevates the risk of Type 2 diabetes and cardiovascular disease. Studies show that women with PCOS and elevated FAI have a 2-4 times higher risk of developing diabetes compared to women with normal androgen levels.

High FAI can also impact reproductive health, contributing to irregular ovulation, reduced fertility, and increased risk of pregnancy complications such as gestational diabetes and preeclampsia. Additionally, the hormonal imbalances associated with elevated FAI may increase the risk of endometrial cancer due to unopposed estrogen exposure from irregular menstrual cycles.

For both men and women, elevated FAI can affect cardiovascular health through multiple mechanisms, including increased inflammation, endothelial dysfunction, and adverse changes in lipid profiles. Regular monitoring of cardiovascular risk factors becomes essential for individuals with persistently high FAI.

Testing and Diagnosis

Accurate diagnosis of elevated FAI requires comprehensive hormone testing that includes both total testosterone and SHBG measurements. A single elevated result may not be diagnostic, as hormone levels can fluctuate based on various factors including time of day, menstrual cycle phase, and stress levels.

The diagnostic process typically involves:

  1. Initial hormone panel including total testosterone, SHBG, and calculated FAI
  2. Additional tests such as DHEA-S, androstenedione, and 17-hydroxyprogesterone to identify the source of excess androgens
  3. Metabolic assessments including fasting glucose, insulin, and lipid panel
  4. Thyroid function tests (TSH, Free T4, Free T3)
  5. For women: LH, FSH, and prolactin to evaluate overall reproductive hormone balance
  6. Imaging studies (ultrasound or MRI) if tumors are suspected

Timing of testing is crucial, particularly for women. Hormone levels should ideally be measured in the early follicular phase (days 3-5 of the menstrual cycle) for the most accurate results. Women on hormonal contraceptives may need to discontinue them for several months before testing to get accurate baseline measurements.

Treatment Approaches for High FAI

Lifestyle Modifications

Lifestyle interventions form the foundation of FAI management and can be remarkably effective, particularly when metabolic factors contribute to the elevation. These modifications address root causes rather than just symptoms:

  • Weight loss: Even a 5-10% reduction in body weight can significantly improve FAI by increasing SHBG and reducing insulin resistance
  • Dietary changes: Low-glycemic index diets, Mediterranean-style eating patterns, and reduced sugar intake help improve insulin sensitivity
  • Regular exercise: Both aerobic exercise and strength training improve insulin sensitivity and can help normalize hormone levels
  • Stress management: Techniques like meditation, yoga, and adequate sleep help regulate cortisol and improve overall hormone balance
  • Limiting alcohol consumption: Alcohol can suppress SHBG production and worsen hormonal imbalances

Medical Treatments

When lifestyle modifications alone are insufficient, various medical treatments can help normalize FAI levels. The choice of treatment depends on the underlying cause, symptom severity, and individual patient factors such as desire for pregnancy.

For women with PCOS or idiopathic hyperandrogenism, combined oral contraceptives are often first-line therapy. These medications suppress ovarian androgen production and increase SHBG levels, effectively lowering FAI. Anti-androgen medications like spironolactone or finasteride may be added for persistent symptoms, though these require careful monitoring and contraception due to potential effects on male fetal development.

Metformin, traditionally used for diabetes management, can be beneficial for women with insulin resistance and elevated FAI. By improving insulin sensitivity, metformin indirectly helps normalize androgen levels and may restore regular menstrual cycles. Some women also experience modest weight loss with metformin, further contributing to hormonal improvement.

Monitoring and Long-term Management

Successfully managing elevated FAI requires ongoing monitoring and adjustment of treatment strategies. Initial follow-up testing should occur 3-6 months after starting treatment to assess response and adjust therapy as needed. Once levels normalize, annual monitoring helps ensure continued control and early detection of any changes.

Long-term management should include regular screening for associated conditions such as diabetes, cardiovascular disease, and metabolic syndrome. Women with PCOS and elevated FAI should undergo glucose tolerance testing every 1-3 years, depending on risk factors. Lipid profiles, blood pressure monitoring, and assessment of cardiovascular risk factors should be part of routine care.

Patient education plays a crucial role in successful long-term management. Understanding the connection between lifestyle factors and hormone levels empowers individuals to make sustainable changes. Support groups, whether in-person or online, can provide valuable peer support and practical tips for managing symptoms and maintaining treatment adherence.

The Path Forward: Taking Control of Your Hormonal Health

A high Free Androgen Index represents more than just a laboratory abnormality—it's a window into your overall hormonal and metabolic health. While the symptoms and health implications can feel overwhelming, understanding your FAI levels provides a roadmap for targeted interventions that can significantly improve your quality of life.

The key to successful management lies in comprehensive evaluation, personalized treatment approaches, and consistent monitoring. Whether through lifestyle modifications, medical treatments, or a combination of both, most people with elevated FAI can achieve significant improvement in their symptoms and reduce their risk of long-term complications.

Remember that hormonal balance is not achieved overnight. Be patient with your body as it responds to treatment, and work closely with healthcare providers who understand the complexities of hormonal health. With the right approach and support, you can optimize your hormone levels and enjoy better overall health and wellbeing.

References

  1. Rosenfield, R. L., & Ehrmann, D. A. (2016). The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews, 37(5), 467-520.[PubMed][DOI]
  2. Deswal, R., Narwal, V., Dang, A., & Pundir, C. S. (2020). The prevalence of polycystic ovary syndrome: a brief systematic review. Journal of Human Reproductive Sciences, 13(4), 261-271.[PubMed][DOI]
  3. Keevil, B. G., & Adaway, J. (2019). Assessment of free testosterone concentration. Journal of Steroid Biochemistry and Molecular Biology, 190, 207-211.[PubMed][DOI]
  4. Teede, H. J., Misso, M. L., Costello, M. F., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clinical Endocrinology, 89(3), 251-268.[PubMed][DOI]
  5. Pasquali, R., & Oriolo, C. (2019). Obesity and androgens in women. Frontiers of Hormone Research, 53, 120-134.[PubMed][DOI]
  6. Goldman, A. L., Bhasin, S., Wu, F. C., Krishna, M., Matsumoto, A. M., & Jasuja, R. (2017). A reappraisal of testosterone's binding in circulation: physiological and clinical implications. Endocrine Reviews, 38(4), 302-324.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my Free Androgen Index at home?

You can test your Free Androgen Index at home with SiPhox Health's Hormone Focus Program, which includes Free Androgen Index testing along with comprehensive hormone panels for both men and women. The program provides CLIA-certified lab results with personalized insights delivered directly to your smartphone.

What's the difference between Free Androgen Index and free testosterone?

While both measure available testosterone, they use different methods. Free testosterone directly measures unbound testosterone in the blood, while FAI is a calculated value using total testosterone and SHBG levels. FAI is often more reliable and cost-effective than direct free testosterone measurements, which can be technically challenging and expensive.

Can high FAI be reversed naturally?

Yes, many people successfully lower their FAI through lifestyle changes including weight loss, dietary improvements, regular exercise, and stress management. These natural approaches are particularly effective when insulin resistance or metabolic factors contribute to the elevation. However, some underlying conditions may require medical treatment in addition to lifestyle modifications.

How long does it take to see improvements in FAI levels?

With consistent lifestyle changes or medical treatment, initial improvements in FAI can often be seen within 3-6 months. However, the timeline varies based on the underlying cause, treatment approach, and individual factors. Symptoms like acne or hirsutism may take longer to improve even after hormone levels normalize.

Should men be concerned about high FAI?

While men naturally have higher FAI levels than women, excessively high levels can indicate underlying health issues or external testosterone use. High FAI in men may increase cardiovascular risks, contribute to mood changes, and paradoxically reduce fertility. Men with symptoms or risk factors should discuss testing with their healthcare provider.

What other tests should be done alongside FAI?

Comprehensive evaluation typically includes total testosterone, SHBG, DHEA-S, metabolic markers (glucose, insulin), thyroid function tests, and for women, reproductive hormones like LH, FSH, and prolactin. These additional tests help identify the underlying cause of elevated FAI and guide appropriate treatment strategies.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details